These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16922892)

  • 1. Emergency coronary artery bypass grafting: a moving target.
    Buxton BF
    ANZ J Surg; 2006 Sep; 76(9):767. PubMed ID: 16922892
    [No Abstract]   [Full Text] [Related]  

  • 2. Percutaneous coronary intervention versus coronary-artery bypass grafting.
    Edwards JL
    N Engl J Med; 2009 Jun; 360(25):2672-3; author reply 2674-5. PubMed ID: 19537314
    [No Abstract]   [Full Text] [Related]  

  • 3. Diabetic multivessel disease: stenting vs. coronary artery bypass grafting.
    Bansilal S; Farkouh M; Sharma S; Fuster V
    Indian Heart J; 2007; 59(2 Suppl B):B72-82. PubMed ID: 19153439
    [No Abstract]   [Full Text] [Related]  

  • 4. Optimizing outcomes for patients with severe carotid and coronary disease.
    Casserly IP
    Catheter Cardiovasc Interv; 2009 Feb; 73(2):143-4. PubMed ID: 19156876
    [No Abstract]   [Full Text] [Related]  

  • 5. eComment: Yes we can. But should we?
    Uva MS
    Interact Cardiovasc Thorac Surg; 2009 Aug; 9(2):281. PubMed ID: 19628541
    [No Abstract]   [Full Text] [Related]  

  • 6. Pituitary apoplexy and CABG: should we change our strategy?
    Levy E; Korach A; Merin G; Feinsod M; Glenville B
    Ann Thorac Surg; 2007 Oct; 84(4):1388-90. PubMed ID: 17889010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased mortality and perioperative complications in patients with previous elective percutaneous coronary interventions undergoing coronary artery bypass surgery.
    Bonaros N; Hennerbichler D; Friedrich G; Kocher A; Pachinger O; Laufer G; Bonatti J
    J Thorac Cardiovasc Surg; 2009 Apr; 137(4):846-52. PubMed ID: 19327507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supplementation of magnesium to warm blood hyperkalemic cardioplegia for the prevention of atrial fibrillation after coronary artery bypass grafting.
    Reşatoğlu AG; Uymaz OK; Akbulut B; Yener A
    Anadolu Kardiyol Derg; 2007 Jun; 7(2):230. PubMed ID: 17513237
    [No Abstract]   [Full Text] [Related]  

  • 9. Stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: a meta-analysis of comparative studies.
    Takagi H; Kawai N; Umemoto T
    J Thorac Cardiovasc Surg; 2009 Jan; 137(1):e54-7. PubMed ID: 19154888
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug-eluting stents or drug-eluting conduits for multivessel disease?
    Alfieri O; Maisano F; Benussi S; Toracca L; Castiglioni A
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):359-61. PubMed ID: 17443103
    [No Abstract]   [Full Text] [Related]  

  • 11. Lipid-lowering effect of preoperative statin therapy on postoperative major adverse cardiac events after coronary artery bypass surgery.
    Thielmann M; Neuhäuser M; Marr A; Jaeger BR; Wendt D; Schuetze B; Kamler M; Massoudy P; Erbel R; Jakob H
    J Thorac Cardiovasc Surg; 2007 Nov; 134(5):1143-9. PubMed ID: 17976441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. For which patients with left main stem disease is percutaneous intervention rather than coronary artery bypass grafting the better option?
    Malvindi PG; Dunning J; Vitale N
    Interact Cardiovasc Thorac Surg; 2008 Apr; 7(2):306-14. PubMed ID: 18194978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary artery bypass grafting versus stenting for unprotected left main coronary artery disease: where lies the body of proof?
    Shemin RJ
    Circulation; 2008 Dec; 118(23):2326-9. PubMed ID: 19047591
    [No Abstract]   [Full Text] [Related]  

  • 14. Multivessel coronary artery disease: how do we treat it?
    Sharma S
    Timely Top Med Cardiovasc Dis; 2007 Jul; 11():E15. PubMed ID: 18297143
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term clinical outcome of coronary artery stenting or coronary artery bypass grafting in patients with multiple-vessel disease.
    Kohsaka S; Goto M; Virani S; Lee VV; Aoki N; Elayda MA; Reul RM; Wilson JM
    J Thorac Cardiovasc Surg; 2008 Aug; 136(2):500-6. PubMed ID: 18692664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting post minimally invasive direct coronary artery bypass grafting incidence of myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting and mortality of cardiac origin.
    Kofidis T; Gerd Paeschke H; Lichtenberg A; Emmert M; Woitek F; Didilis V; Haverich A; Klima U
    Interact Cardiovasc Thorac Surg; 2009 Jan; 8(1):49-53. PubMed ID: 18786942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin and mortality from coronary bypass surgery.
    Karzai W; Priebe HJ
    N Engl J Med; 2003 Mar; 348(11):1057-9; author reply 1057-9. PubMed ID: 12638576
    [No Abstract]   [Full Text] [Related]  

  • 18. Multivessel disease: percutaneous coronary intervention for classic coronary artery bypass grafting indications.
    Brar SS; Syros G; Dangas G
    Angiology; 2008; 59(2 Suppl):83S-8S. PubMed ID: 18544582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug-eluting stents can increase the risk of late stent thrombosis].
    Skyttberg N; Linder R; Carlsson J
    Lakartidningen; 2006 Sep 27-Oct 3; 103(39):2845-7. PubMed ID: 17128916
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anticoagulants, platelet antiaggregants after aortocoronary bypass?].
    Nicolas G
    Ann Cardiol Angeiol (Paris); 1990 Dec; 39(10):613-6. PubMed ID: 2291614
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.